PDL BioPharma Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 80.1 | 67.0 | 78.8 |
| Net Investing Cash Flow | 587.0 | 72.7 | (116.0) |
| Net Financing Cash Flow | (878.5) | 22.0 | 32.9 |
| Net Change in Cash | (211.4) | 161.6 | (4.4) |
| Depreciation & Amortization | 22.5 | 64.5 | 75.7 |
| Capital Expenditures | (3.3) | (94.7) | (36.5) |
| Cash Dividends Paid | (506.6) | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
